RSS

SEA Vision

Here EPM speaks to a number of major pharma players to get their thoughts on what FMD means for the industry. Read more

Opinion

As we draw ever nearer to the time that compliance with the European Falsified Medicines Directive (FMD) is required, we discuss the value of serialisation beyond compliance and outsourcing with six leading solutions providers. Read more

Latest Issue

Paolo Landriani, technical department director at SEA Vision, discusses the importance of the right equipment and software in this approach and how it can save space, improve quality and ultimately save manufacturers time and money. Read more

Opinion

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. Read more

News

In this article, Marco Baietti, commercial director at SEA Vision, weighs up the advantages of implementing aggregation, what the future holds and the current levels of adoption within the industry. Read more

Opinion

After the successful first day we take a brief glance at what can be enjoyed today, day two of the pharma and biotech manufacturing event, Interphex… Read more

News

Today (Monday 27 November) marks the original deadline date for the DSCSA. While the FDA has delayed its enforcement of compliance with these serialisation requirements by a year, pharma is still required to legally comply. Industry tells us more… Read more

Opinion

Welcome to our preview of exciting news and developments from day 2 of this year’s CPhI exhibition in Frankfurt. Read more

News

Recent research from serialisation software provider, SEA Vision, and life sciences technology firm, Zenith Technologies, has revealed that for the majority of industry professionals the cost of implementing serialisation is the biggest barrier Read more

Analysis

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. Read more

News

Are you preparing for serialisation? Carlos Machado, SEA Vision US, explores some of the challenges and opportunities companies are facing when preparing for serialisation and outlines some steps to success for those that are yet to make a start. Read more

Opinion

According to research recently performed by SEA Vision and Zenith Technologies, 40% of pharmaceutical industry professionals are lacking confidence in their ability to meet the upcoming US and European serialisation deadlines. Read more

Analysis

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. Read more

News

According to research conducted by serialisation system provider SEA Vision and life science technology specialist Zenith Technologies, technology selection is the biggest challenge for companies preparing for serialisation regulations. Read more

News